Wai Yuen Tong Medicine (HKG:0897) is planning to propose a reduction in share premium at its upcoming annual general meeting, according to a Friday Hong Kong bourse filing.
As of March 31, the company's share premium account had a balance of around HK$1.12 billion, according to financial statements.
The company believes the move will facilitate the payment of dividends in the future depending on its financial condition.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.